Identification and Actions of the Maresin 1 Metabolome in Infectious Inflammation
- 1 December 2016
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 197 (11) , 4444-4452
Abstract
Maresin 1 (MaR1) is an immunoresolvent that governs resolution of acute inflammation, and its local metabolism in the context of infectious inflammation is of interest. In this study, we investigated the MaR1 metabolome in infectious exudates and its bioactions in regulating leukocyte responses in the context of bacterial infection. In Escherichia coli infectious exudates, MaR1 was temporally regulated with maximal levels at 4 h (2.2 ± 0.4 pg/lavage). In these exudates we also identified two novel products, and their structure elucidation gave 22-hydroxy-MaR1 and 14-oxo-MaR1. Using human primary leukocytes, we found that neutrophils primarily produced 22-OH-MaR1, whereas the main macrophage product was 14-oxo-MaR1. Both 22-OH-MaR1 and 14-oxo-MaR1 incubated with human primary macrophages gave dose-dependent increases in macrophage phagocytosis of ∼75% at 1 pM 22-OH-MaR1 and ∼25% at 1 pM 14-oxo-MaR1, whereas 14-oxo-MaR1 was less active than MaR1 at higher concentrations. Together these findings establish the temporal regulation of MaR1 during infectious inflammation, and elucidate the structures and actions of two novel MaR1 further metabolites that carry bioactivities.Keywords
This publication has 35 references indexed in Scilit:
- Distinct bone marrow-derived and tissue-resident macrophage lineages proliferate at key stages during inflammationNature Communications, 2013
- Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediatorsBlood, 2012
- Infection regulates pro-resolving mediators that lower antibiotic requirementsNature, 2012
- Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls painThe FASEB Journal, 2012
- Eosinophils promote resolution of acute peritonitis by producing proresolving mediators in miceThe FASEB Journal, 2010
- Resolvin D1 binds human phagocytes with evidence for proresolving receptorsProceedings of the National Academy of Sciences, 2010
- Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actionsJournal of Experimental Medicine, 2008
- Resolvin D1 and Its Aspirin-triggered 17R EpimerJournal of Biological Chemistry, 2007
- Metabolic Inactivation of Resolvin E1 and Stabilization of Its Anti-inflammatory ActionsJournal of Biological Chemistry, 2006
- Identification and biological activity of novel ω‐oxidized metabolites of leukotriene B4 from human leukocytesFEBS Letters, 1981